AGP Executive Report
Last update: 10 hours agoFactory Expansion: KYZEN opened a new Penang facility to expand production and technical support for semiconductor, electronics, automotive and medical-device customers. Penang says US firms invested RM18.2 billion in its manufacturing sector from 2020 through the first half of 2026. Solar Manufacturing: Tata Power’s TP Solar produced 1 GW of modules and 0.9 GW of cells in the July–September quarter, reaching 2 GW of modules and 1.8 GW of cells for the half-year. Healthcare Supply Chains: IFC plans a $10 million loan to Kenya’s Revital Healthcare for cold-chain capacity and a logistics hub; South Africa has also launched the FuturePharma facility to support local medicine and vaccine production. Trade and Capacity: India joined the US, EU and 13 other economies in a new initiative to address excess capacity in EVs, batteries, chemicals, semiconductors and solar panels. Vehicle Production: Jaguar’s new Type 01 is slated for Solihull production in 2027, with battery packs and drive units made in Wolverhampton and body panels in Merseyside. Pharma Investment: Bayer plans a $2.2 billion pharmaceutical manufacturing site in Ohio.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.